Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Seagen Inc.
Age
6–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histologically-confirmed NHL (DLBCL only for Parts B and C)
Relapsed or refractory disease following at least 1 prior systemic therapy
Measurable disease of at least 1.5 cm as documented by CT
Eastern Cooperative Oncology Group (ECOG) performance status less than or equal to 2
You may not be if
History of another primary invasive malignancy that has not been in remission for at least 3 years
Current diagnosis of systemic or cutaneous anaplastic large cell lymphoma or mycosis fungoides
B cell lymphoma previously treated with only single-agent rituximab (for patients receiving brentuximab vedotin only) or corticosteroids as monotherapy
